Amr Al-Haidari, PhD

Cancer researcher

 

PROFESSIONAL SUMMARY

Highly dedicated and accomplished scientist specialized in cancer research with a proven track record of contributing to the advancement of cancer science. Possessing a solid background in clinical/ preclinical research as well as in translational cancer research. Well-practiced in drafting corresponding technical and research documents with demonstrated 5 years of teaching in higher education. My teaching philosophy revolves around cultivating a passion for critical thinking and evidence-based practice, preparing the next generation of scientists to tackle the future challenges in cancer research. Highly experienced in designing and driving pre-clinical cancer research projects with the ability to move the findings to translational medicine and the clinical bench. Passionate to motivate people to work together towards shared goals and build long-lasting mutual relationships. The main interest is in immuno-oncology and tumor microenvironment research.

EDUCATION

2018: PhD         Lund University, Clinical sciences department, Sweden   

Dissertation: “Chemokine-Mediated colon cancer cell migration”

2012: MSc        Lund University, Center of Molecular Protein Science, Sweden    

                        Thesis: “Role of Chemokines in colon cancer metastasis”

2004: BA          Sanaa University, Faculty of Medicine, and Health Sciences         

                        Major: Medical laboratory medicine

 

POSITIONS AND SCIENTIFIC APPOINTMENTS

2022-date:       Cancer researcher at Skåne University Hospital.

2020-2022:       Part-time postdoc, Department of Clinical Pathology, Skåne University                                             Hospital affiliated to Lund University.

2013-2018:       Doctoral research student, Lund University, Sweden.

2012-2013:       Research Assistant, Surgery Department, Lund University

2006-2009:       Assistant lecturer of clinical immunology, faculty of medicine, Thamar                                 University, Yemen

2004-2005:       Clinical trainee, Regional clinical laboratories.

 

CLINICAL APPOINTMENTS

2020-date:         Clinical scientist at the department of clinical pathology, Skåne University                            Hospital. Assist in providing diagnosis and therapy follow-up for patients with                            blood cancers using advanced multiparametric flow cytometry technology.

 

                         Clinical tutor in hematopathology. I receive students from biomedicine program for                          clinical research projects and training in clinical flow cytometry in the diagnosis                          and therapy follow-up of blood cancers.

 

CURRENT RESEARCH INTERESTS

• Tumor microenvironment.
• Premetastatic niche formation.
• Extracellular vesicles (EV)-based immunotherapy.
• EV-based delivery system of therapeutic miRNAs.
• EVs as cancer diagnostic, prognostic, and therapeutic markers.
• Regulation of cancer transcriptome.

 

DISEASE AREA OF FOCUS

• Blood cancer: Leukemia, Lymphoma, and Multiple Myeloma.
• Peritoneal metastasis of colorectal and Ovarian cancers.

 

CURRENT TEACHING INTERESTS

• Cancer cell biology
• Cancer immunology
• Role of extracellular vesicles in cancer metastasis

 

TEACHING EXPERIENCE

2023:    Module Name: BIMB10. Biomedicine program, Lund University.

Teaching undergraduate biomedicine lab course 30 credits: ‘’The biology and chemistry of the cell’’. Total Students: 40

           

2023: Module Name: Master’s degree research project in molecular biology, Lund University.

Supervising undergraduate research projects for university students.

Current student: Antony Truong, degree thesis: master’s degree 2023, Project title: Therapeutic applications of miRNAs in FLT3+ Acute Myeloid Leukemia.

           

2022: Module Name: bachelor’s degree research projects, Lund University.

Supervising undergraduate research projects for university students.

Former student: Asyel Jabbar, degree thesis: bachelor’s degree 2022, Project title: Validation of exosome’s yield and purity for clinical biomarkers discovery using polymer precipitation and size exclusion chromatography methods.

           

2006-2009 Module Name: Immunology and biochemistry, Thamar University, Yemen

     Teaching undergraduate courses. 2 semesters, total Students: 70.     

 

• Contributed to course design for tumor markers for undergraduate students in medical laboratories department, faculty of medicine, Thamar University, Yemen.
• Coordinated departmental boards for annual syllabus review of immunology and biochemistry courses, faculty of medicine, Thamar University, Yemen.

 

Teaching techniques used:

• Team-based learning.
• Problem-based learning.
• Inquiry-based learning.
• Overhead and PowerPoint presentations.
• Instructor and Peers feedback.
• CATs assessment strategies.
• Reports evaluation and assignments and exams correction and feedback.

 

NATIONAL AND INTERNATIONAL SCIENTIFIC PARTICIPATION

• 2024 Upcoming: 8^th Cancer World Congress, Dubrovnik, Croatia, poster presentation: MiR-155 inhibits FLT3-ITD-induced Cell Proliferation and Survival of Human Acute Myeloid Leukemia Cells.
• 2018: World gastroenterology conference, Paris, poster presentation: MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).
• 2016 & 2017: MCC; invited speaker, Sweden: Neutrophil extracellular traps promote surgery trauma-induced peritoneal carcinosis of metastatic colorectal cancer via modulation of CXCR2 and αv integrin.
• 2016: World GI cancer congress, Barcelona, Poster presentation: Neutrophil extracellular traps promote surgery-induced peritoneal carcinosis of metastatic colorectal cancer via modulation of CXCR2 and αv integrin.
• 2016: Cancer therapy and molecular biomarkers, Berlin, oral presentation: MiR-155-5p positively regulates colon cancer cell migration by targeting RhoA.
• 2015: European cancer congress, Vienna, Poster presentation: MiR-155 regulates CCL17 - induced colon cancer cell migration by targeting RhoA.
• 2015: The faculty of health sciences, Islamic University of Gaza, invited lecture: Simvastatin as a potential drug against colon cancer metastasis.
• 2014& 2015: MCC; Malmö cancer center retreats, Skåne, Sweden Poster presentation.
• 2014: Cancer therapy and cancer controlling summit, London, invited speaker: HMG-COA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.

           

PROFESSIONAL ACTIVITIES

Referee for Peer-Reviewed Journals:

• Review Editor with Frontiers in Cell and Developmental Biology Journal
• Reviewer in Advances in clinical and experimental medicine Journal
• Reviewer in BMC cancer Journal
• Reviewer in Frontiers Genetics Journal
• Reviewer in Journal of International Medical Research

 

Membership

• Future faculty member, Lund University
• Guest member of European Association of Hematology, EHA.

 

CERTIFIED COURSES

• 2023: Research supervision, Lund University.
• 2023: Perspectives on Learning, Lund University.
• 2020: Teaching Science at University, University of Zurich.
• 2019: Project management, University of California.
• 2019: Genomics technologies, Johns Hopkins University.
• 2019: Clinical Trials, Göteborg University.
• 2018: Mass spectrometry, Lund University.
• 2016: Professional Poster designs, Lund University.
• 2012: Animal lab-work license, Lund University.

 

INTERPERSONAL SKILLS

• Communication skills and Organizational / managerial skills.
• Independent and team player.
• Critical thinking and Problem solving.
• Motivated and team leading.
• Project management.
• Desire to learn.
• Adaptability and Creativity.
• Professional use of computer or web-based digital tools.